🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥

News

Pods

Back

Nimesh Pinnamaneni
•

Helixworks Technologies • 1m

From ₹51 Cr to ₹1,272 Cr in a year—this Indian biotech’s revenue chart is insane. 💰 Molbio is going public targeting ₹22,000–24,000 Cr valuation. IPO expected in November 2025, raising ₹2,200–2,400 Cr. 🔬 Their Truenat platform, is a battery-power

Anonymous 4

Hey I am on Medial • 1m

As someone who actually used both Cepheid and Truenat systems during COVID (I work in hospital administration), there are significant differences. Cepheid is more user-friendly with fully integrated cartridges but costs 3-4x more per test. Truenat requires more manual steps but is much more cost-effective. In wealthy countries, Cepheid wins easily. In resource-limited settings, Truenat has a massive advantage. The question for investors is where the growth will come from. If Molbio stays focused on emerging markets, they could build a sustainable business. If they try to compete head-on with Cepheid in developed markets, they'll likely fail. Their valuation assumes they'll succeed everywhere, which is unrealistic.

1 replies3 likes

Replies (1)

Nimesh Pinnamaneni
•

Helixworks Technologies • 1m

Interesting insight on their go-to-market. I thought Truenat is also a sample-to-answer solution—doesn’t require any pre-processing. Is the manual step you’re referring to in nucleic acid extraction, or something else?

0 replies

Recommendations from Medial

Nimesh Pinnamaneni
•

Helixworks Technologies • 1m

10 replies40 likes

Nimesh Pinnamaneni
•

Helixworks Technologies • 1m

Why qPCR & Phenotypic Testing Must Be Displaced? – Part III This is the third part of a deep dive into why qPCR & phenotypic testing need to be replaced. In Part I, I covered the limitations of current diagnostics & why incremental improvements aren

0 replies2 likes

Mohit Mittal_KMC

Hey I am on Medial • 3m

Do a startup making incense sticks/cones from waste flowers would work in urban Markets? Considering the end product is 3-5x more expensive than the established incense stick manufacturers ?

2 replies4 likes

Chamarti Sreekar

Passionate about Pos... • 2m

The Future is Being Built Right Now – And This is MASSIVE $20 billion. That’s the valuation Safe Superintelligence is now chasing—a 4X jump in just a few months. This isn’t just another AI startup raising capital. This is the birth of something monu

1 replies19 likes

TREND talks

History always repea... • 3m

🐶 Department of Government Efficiency (DOGE), led by Elon Musk, continues its work. This time, attention has turned to the fact that the Joe Biden administration is spending massive amounts of money to "eliminate racism" in animals. 🐾 They discove

5 replies16 likes

Anonymous

Hey I am on Medial • 10m

Secrets and leadership of the biggest consumer banks. DImon Is truly a giant and powerhouse. Who can make, break, follow on and destroy trends in financial markets. Even though his image is of a family man. His power in the financial markets is unm

0 replies4 likes

Mohit Kumar

Entrepreneur | App &... • 11m

How is Indian AR VR Markets ? Do you know any startups who are doing wonderful in VR Market?

1 replies2 likes

Mahendra Lochhab

Content creator • 9m

India's insurance market is the 10th largest in the world and the second largest in emerging markets, with an estimated 1.9% market share.

1 replies3 likes

Anonymous

Hey I am on Medial • 1y

Are duopolies inevitable in certain markets and industries ? Is this better than 4 to 5 firms competing with each other ?

4 replies8 likes

Kimiko

Posts about startup ... • 1m

A stock broker is very important aspect when considering your trading journey. Here is a deep insight on which brokers are leading in Indian Financial Markets